MYELODYSPLASIA OCCURRING AFTER FLUDARABINE TREATMENT FOR CHRONIC LYMPHOCYTIC-LEUKEMIA

Authors
FREWIN RJ PROVAN D SMITH AG
Citation
Rj. Frewin et al., MYELODYSPLASIA OCCURRING AFTER FLUDARABINE TREATMENT FOR CHRONIC LYMPHOCYTIC-LEUKEMIA, Clinical and laboratory haematology, 19(2), 1997, pp. 151-152
Citations number
10
Categorie Soggetti
Hematology
Journal title
Clinical and laboratory haematology → ACNP
ISSN journal
01419854
Volume
19
Issue
2
Year of publication
1997
Pages
151 - 152
Database
ISI
SICI code
0141-9854(1997)19:2<151:MOAFTF>2.0.ZU;2-M
Abstract
The purine analogue, fludarabine, is of proven efficacy in the treatme nt of lymphoid malignancies. The drug appears to be well tolerated wit h minimal side-effects, and few toxicities have been observed, A case of myelodysplasia occurring after therapy with fludarabine is presente d and its implications are discussed.